Bibliografía del artículo
1. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 352:804-815, 2005.
2. Hernández JA, González M, Hernández JM. Chronic lymphoid leukemia. Med Clin (Barc) 135:172-178, 2010.
3. Binet JL, Auquier A, Dighiero G, y col. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48:198-206, 1981.
4. Rai KR, Sawitsky A, Cronkite EP, y col. Clinical staging of chronic lymphocytic leukemia. Blood 46:219-234, 1975.
5. Nowakowski GS, Hoyer JD, Shanafelt TD, y col. Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic test. Mayo Clin Proc 82:449-453, 2007.
6. Rozman C, Montserrat E, Rodríguez-Fernández JM, y col. Bone marrow histologic pattern--the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. Blood 64:642-648, 1984.
7. Geisler CH, Hou-Jensen K, Jensen OM, y col. The bone-marrow infiltration pattern in B-cell chronic lymphocytic leukemia is not an important prognostic factor. Danish CLL Study Group. Eur J Haematol 57:292-300, 1996.
8. Viñolas N, Reverter JC, Urbano-Ispizua A, y col. Lymphocyte doubling time in chronic lymphocytic leukemia: an update of its prognostic significance. Blood Cells 12:457-470, 1997.
9. Hallek M, Wanders L, Ostwald M, y col. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma. Leuk Lymphoma 22:439-447, 1996.
10. Wierda WG, O'Brien S, Wang X, y col. Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia. Blood 109:4679-4685, 2007.
11. Ferrajoli A, Manshouri T, Estrov Z, y col. High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia. Clin Cancer Res 7:795-799, 2001.
12. Ghia P, Guida G, Stella S, y col. The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression. Blood 101:1262-1269, 2003.
13. Hamblin TJ, Orchard JA, Ibbotson RE, y col. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 99:1023-1029, 2002.
14. Crespo M, Bosch F, Villamor N, y col. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 348:1764-1775, 2003.
15. Rassenti LZ, Huynh L, Toy TL, y col. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 351:893-901, 2004.
16. Damle RN, Wasil T, Fais F, y col. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94:1840-1847, 1999.
17. Hamblin TJ, Davis Z, Gardiner A, y col. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94:1848-1854, 1999.
18. Dohner H, Stilgenbauer S, Benner A, y col. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343:1910-1916, 2000.
19. Hernández JA, Rodríguez AE, González M, y col. A high number of losses in 13q14 chromosome is associated with a worse outcome and biological differences in patients with B chronic lymphoid leukemia. Haematologica 94:364-371, 2009.
20. Cavazzini F, Hernandez JA, Gozzetti A, y col. Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukemia identify a disease subset with poor prognosis. Br J Haematol 142:529-537, 2008.
21. Stilgenbauer S, Sander S, Bullinger L, y col. Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival. Haematologica 92:1242-1245, 2007.
22. Calin GA, Ferracin M, Cimmino A, y col. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353:1793-1801, 2005.
23. Oppezzo P, Vasconcelos Y, Settegrana C, y col. The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia. Blood 106:650-657, 2005.
24. Klein U, Tu Y, Stolovitzky GA, y col. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 194:1625-1638, 2001.
25. Rosenwald A, Alizadeh AA, Widhopf G, y col. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 194:1639-1647, 2001.
26. Rodriguez AE, Robledo C, Garcia JL, y col. Identification of a novel recurrent gain on 20q13 in chronic lymphocytic leukemia by array CGH and gene expression profiling. Ann Oncol (epub ahead jan 2012).
27. Prieto-Sanchez RM, Hernandez JA, Garcia JL, y col. Overexpression of the VAV proto-oncogene product is associated with b-cell chronic lymphocytic leukaemia displaying loss on 13q. Br J Haematol 133:642-645, 2006.
28. Zenz T, Fröling S, Mertens D, y col. Moving from prognostic to predictive factors in chronic lymphocytic leukaemia. Best Pract Res Clin Haematol 23:71-84, 2010.
29. Del Poeta G, Del Principe MI, Maurillo L, y col. Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia. Leuk Lymphoma 51:95-106, 2010.
30. Buggins AG, Levi A, Gohil S, y col. Evidence for a macromolecular complex in poor prognosis CLL that contains CD38, CD49d, CD44 and MMP-9. Br J Haematol 154:216-222, 2011.
31. Kainz B, Shehata M, Bilban M, y col. Overexpression of the paternally expressed gene 10 (PEG10) from the imprinted locus on chromosome 7q21 in high-risk B-cell chronic lymphocytic leukemia. Int J Cancer 121:1984-1993, 2007.
32. Sellmann L, de Beer D, Bartels M, y col. Telomeres and prognosis in patients with chronic lymphocytic leukaemia. Int J Hematol 93:74-82, 2011.
33. Hancer VS, Diz-Kucukkaya R, Aktan M. Overexpression of Fc mu receptor (FCMR, TOSO) gene in chronic lymphocytic leukemia patients. Med Oncol 29:1068-1072, 2012.
34. Wang L, Lawrence MS, Wan Y, y col. SF3B1 and other novel genes in chronic lymphocytic leukemia. N Engl J Med 365:2497-2506, 2011.
35. Puente XS, Pinyol M, Quesada V, y col. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukemia. Nature 475:101-105, 2011.
36. Quesada V, Conde L, Villamor N, y col. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 44:47-52, 2011.